gsthr logo
Quick links to detailed datasheets for United States of America at gsthr.org

Smoking in United States of America

In the United States of America, smoking is allowed but tobacco products should follow some regulations. Under these regulations, health warnings on tobacco packaging including cigarettes are mandatory, the minimum legal age for their sales is 21 years, and there are no federal legal restrictions on smoking in public places. While tobacco advertising is regulated, not all forms of their advertising are banned. An excise tax of 32.16% with a total taxation rate of 37.36% is applied on cigarettes. Cigarettes can legally be sold with authorised documents. They may also be purchased through vending machines as well as through online channels. Importing cigarettes for trade is allowed with an appropriate import license. Despite these control measures, prevalence data show that smoking remains an important public health issue in the United States. There were 39.8 million current smokers in the country in 2024. This represents an overall adult smoking prevalence of 14.1%, with higher prevalence among men (17.1%) than among women (11.1%). In comparison, the overall current smoking prevalence was 12.3% in 2022. The adult daily smoking prevalence was recorded to be 10.01% in 2020. Smoking-related mortality also remains significant in the country. In 2021, smoking resulted in 360,370 deaths, including 216,986 male deaths and 143,383 female deaths. This shows that smoking accounted for 10.38% of all deaths in the United States in 2021, with a higher rate among men (11.9%) than among women (8.7%).

Read articles from United States of America

July 01, 2026 by fda.gov

FDA Authorizes 20 ZYN Nicotine Pouches to Be Marketed with Specific Modified Risk Claim

The FDA’s authorisation of modified risk claims for 20 ZYN nicotine pouch products marks an important step for evidence-based nicotine communication. Adults who smoke should be able to receive clear information that switching completely from cigarettes to authorised smoke-free products can reduce specific disease risks. The decision recognises that not all nicotine products carry the same harm, and that accurate relative-risk messaging can support better choices. Public health should make lower-risk information visible, not harder to say.

June 30, 2026 by regulatorwatch.com

Battleground Vape | U.S. Vaping Industry Continues Court Fight | RegWatch

The US vape court battles show how contested the future of harm reduction has become. While cigarettes remain widely available, regulated vaping products face years of legal uncertainty, approval delays and enforcement disputes. For adult smokers, that means fewer reliable routes away from combustible tobacco. Public health policy should protect young people without keeping lower-risk alternatives trapped in a regulatory battleground.

June 30, 2026 by regulatorwatch.com

Battleground Vape | U.S. Vaping Industry Continues Court Fight | RegWatch

The US vape court battles show how contested the future of harm reduction has become. While cigarettes remain widely available, regulated vaping products face years of legal uncertainty, approval delays and enforcement disputes. For adult smokers, that means fewer reliable routes away from combustible tobacco. Public health policy should protect young people without keeping lower-risk alternatives trapped in a regulatory battleground.

June 29, 2026 by clearingtheair.eu

Vape flavour restrictions could weaken smoking quit attempts, studies suggest

Vape flavour restrictions may weaken quit attempts by making lower-risk alternatives less appealing to adult smokers. Flavours can help people move away from the taste and ritual of cigarettes, supporting a clearer break from combustible tobacco. Protecting young people is essential, but broad flavour bans risk removing one of the tools that helps smokers switch. Evidence-based policy should target youth access without undermining adult cessation.

June 24, 2026 by reason.com

Secret Emails Reveal Sketchy Tactics in California Public Health's Tobacco Ban 'Endgame'

Public records from California raise troubling questions about how tobacco “endgame” policies are being advanced. When health agencies and funded partners coordinate messaging, polling and local campaigns behind the scenes, public consultation risks becoming political theatre rather than genuine debate. Tobacco policy should be transparent, evidence-based and accountable to the communities it affects. Public health loses trust when outcomes appear to be managed before the public has been heard.

June 24, 2026 by regulatorwatch.com

Where’s the Outrage? | Lack of Urgency Mires U.S. Nicotine Industry | RegWatch

The lack of urgency in US nicotine regulation is leaving adult smokers with fewer legal, lower-risk options while cigarettes remain widely available. Delays, uncertainty and uneven enforcement weaken the regulated market and create space for illicit products to grow. Harm reduction cannot work if safer alternatives are trapped in regulatory limbo. Public health should move faster to support products that help people leave combustion behind.

June 24, 2026 by regulatorwatch.com

Where’s the Outrage? | Lack of Urgency Mires U.S. Nicotine Industry | RegWatch

The lack of urgency in US nicotine regulation is leaving adult smokers with fewer legal, lower-risk options while cigarettes remain widely available. Delays, uncertainty and uneven enforcement weaken the regulated market and create space for illicit products to grow. Harm reduction cannot work if safer alternatives are trapped in regulatory limbo. Public health should move faster to support products that help people leave combustion behind.

June 24, 2026 by regulatorwatch.com

Where’s the Outrage? | Lack of Urgency Mires U.S. Nicotine Industry | RegWatch

The lack of urgency in US nicotine regulation is leaving adult smokers with fewer legal, lower-risk options while cigarettes remain widely available. Delays, uncertainty and uneven enforcement weaken the regulated market and create space for illicit products to grow. Harm reduction cannot work if safer alternatives are trapped in regulatory limbo. Public health should move faster to support products that help people leave combustion behind.

June 23, 2026 by thefp.com

Don’t Freak Out About Fruit-Flavored Vapes

Fruit-flavoured vapes are often treated as a youth problem, but for many adult smokers they are part of what makes switching away from cigarettes work. Flavours can help distance people from the taste and ritual of smoking while keeping them within legal, regulated markets. Protecting young people matters, but panic-driven flavour bans risk removing one of the tools adults use to quit combustible tobacco. Regulation should target youth access without undermining harm reduction.

June 19, 2026 by gfn.tv

THR Unfiltered #1 | Navigating the prohibitionist landscape of THR in the States #GFN26

Tobacco harm reduction in the United States is shaped by a complex mix of prohibitionist pressure, strict regulation and uneven enforcement. While adult smokers continue to need realistic alternatives to combustible cigarettes, access to safer nicotine products is often restricted by policies that prioritise fear over relative risk. The result is a market where legal pathways are difficult, illicit supply can grow and consumers receive confusing messages. A better approach would protect young people while keeping harm reduction visible, regulated and accessible.